BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Canedo-Marroquín G, Saavedra F, Andrade CA, Berrios RV, Rodríguez-Guilarte L, Opazo MC, Riedel CA, Kalergis AM. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments. Front Immunol 2020;11:569760. [PMID: 33362758 DOI: 10.3389/fimmu.2020.569760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hidalgo T, Simón-vázquez R, González-fernández A, Horcajada P. Cracking the immune fingerprint of metal–organic frameworks. Chem Sci . [DOI: 10.1039/d1sc04112f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xiao Y, Lidsky PV, Shirogane Y, Aviner R, Wu CT, Li W, Zheng W, Talbot D, Catching A, Doitsh G, Su W, Gekko CE, Nayak A, Ernst JD, Brodsky L, Brodsky E, Rousseau E, Capponi S, Bianco S, Nakamura R, Jackson PK, Frydman J, Andino R. A defective viral genome strategy elicits broad protective immunity against respiratory viruses. Cell 2021;184:6037-6051.e14. [PMID: 34852237 DOI: 10.1016/j.cell.2021.11.023] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med 2021;218:e20211211. [PMID: 34357402 DOI: 10.1084/jem.20211211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ćavar Zeljković S, Schadich E, Džubák P, Hajdúch M, Tarkowski P. Antiviral Activity of Selected Lamiaceae Essential Oils and Their Monoterpenes Against SARS-Cov-2. Front Pharmacol 2022;13:893634. [DOI: 10.3389/fphar.2022.893634] [Reference Citation Analysis]
5 García-Montero C, Fraile-Martínez O, Bravo C, Torres-Carranza D, Sanchez-Trujillo L, Gómez-Lahoz AM, Guijarro LG, García-Honduvilla N, Asúnsolo A, Bujan J, Monserrat J, Serrano E, Álvarez-Mon M, De León-Luis JA, Álvarez-Mon MA, Ortega MA. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines (Basel) 2021;9:433. [PMID: 33925526 DOI: 10.3390/vaccines9050433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
6 Branco CG, Duarte I, Gameiro J, Costa C, Marques F, Oliveira J, Bernardo J, Fonseca JN, Carreiro C, Braz S, Lopes JA. Presentation and outcomes of chronic kidney disease patients with COVID-19. J Bras Nefrol 2021:S0101-28002021005076301. [PMID: 34762092 DOI: 10.1590/2175-8239-JBN-2021-0071] [Reference Citation Analysis]
7 Vojdani A, Vojdani E, Rosenberg AZ, Shoenfeld Y. The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens. Pathophysiology 2022;29:243-80. [DOI: 10.3390/pathophysiology29020020] [Reference Citation Analysis]
8 Riedel C, Rivera JC, Canedo-Marroquín G, Kalergis AM, Opazo MC. Respiratory viral infections during pregnancy: effects of SARS-CoV-2 and other related viruses over the offspring. J Dev Orig Health Dis 2021;:1-6. [PMID: 33526164 DOI: 10.1017/S2040174420001373] [Reference Citation Analysis]
9 Wack M, Péré H, Demory-Guinet N, Kassis-Chikhani N, Janot L, Vedie B, Izquierdo L, Bélec L, Veyer D. No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris. J Clin Virol 2021;145:104999. [PMID: 34695725 DOI: 10.1016/j.jcv.2021.104999] [Reference Citation Analysis]
10 Jones L, Bakre A, Naikare H, Kolhe R, Sanchez S, Mosley YC, Tripp RA. Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs. PLoS One 2021;16:e0257563. [PMID: 34534259 DOI: 10.1371/journal.pone.0257563] [Reference Citation Analysis]
11 Bohmwald K, Andrade CA, Kalergis AM. Contribution of Pro-Inflammatory Molecules Induced by Respiratory Virus Infections to Neurological Disorders. Pharmaceuticals (Basel) 2021;14:340. [PMID: 33917837 DOI: 10.3390/ph14040340] [Reference Citation Analysis]
12 Reyes H, Diethelm-varela B, Méndez C, Rebolledo-zelada D, Lillo-dapremont B, Muñoz SR, Bueno SM, González PA, Kalergis AM. Contribution of Two-Dose Vaccination Toward the Reduction of COVID-19 Cases, ICU Hospitalizations and Deaths in Chile Assessed Through Explanatory Generalized Additive Models for Location, Scale, and Shape. Front Public Health 2022;10:815036. [DOI: 10.3389/fpubh.2022.815036] [Reference Citation Analysis]
13 Hao M, Wang D, Xia Q, Kan S, Chang L, Liu H, Yang Z, Liu W. Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19. Front Immunol 2022;13:879792. [DOI: 10.3389/fimmu.2022.879792] [Reference Citation Analysis]
14 Garrido-suárez BB, Garrido-valdes M, Garrido G. Reactogenic sleepiness after COVID-19 vaccination. A hypothesis involving orexinergic system linked to inflammatory signals. Sleep Medicine 2022;98:79-86. [DOI: 10.1016/j.sleep.2022.06.011] [Reference Citation Analysis]
15 de-Oliveira-Pinto LM, Fiestas Solórzano VE, de Lourdes Martins M, Fernandes-Santos C, Damasco PH, de Siqueira MAMT, Dias HG, Pauvolid-Corrêa A, Damasco PV, de Azeredo EL. Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients. Viruses 2022;14:455. [PMID: 35336861 DOI: 10.3390/v14030455] [Reference Citation Analysis]